Company ProfilePremium

Cobalt Technologies Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Cobalt Technologies Inc. - Company showcase

Year Founded & Workforce

2005

Cobalt Technologies Inc. logo

Cobalt Technologies Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Cobalt Technologies Inc. Overview

Cobalt Technologies was a Silicon Valley industrial biotechnology start-up that tried to commercialize n-butanol made from non-food cellulosic biomass. It used non-genetically-modified Clostridium strains and, originally, a biofilm-based continuous fermentation process. It presented bio-butanol both as a renewable chemical and as a platform intermediate for jet fuel, plastics and synthetic rubber. The company raised more than USD 90 million across at least five venture rounds. It built a library of 240 strains covering eight species and claimed production costs below USD 700 per tonne. It never reached commercial-scale production. After a management change around 2012, a move away from its core biofilm technology and a long period of public silence, it could not secure further funding. Its headquarters closed and its equipment, intellectual property and strain library were auctioned in 2015. It is now of historical interest only.

Cobalt specialized in producing biobutanol from cellulosic feedstocks, including corn cobs, forestry residues (treetops and limbs) and beetle-killed pine [V]. No annual report exists, so the company's own filed description cannot be quoted.

Business model. The company was a pre-commercial technology developer. Its intended model, as far as public statements show, combined technology licensing and joint development with industrial partners, rather than building and owning plants alone [R]. No product, service, subscription or licensing revenue mix was ever disclosed.

Value chain position. Cobalt sat upstream, between biomass suppliers and chemical or fuel producers. Its technology covered biomass-to-sugar conversion, fermentation to n-butanol and strain improvement [V].

Customer types and end-markets. Target end-markets were n-butanol for paints, coatings and solvents; renewable jet fuel; and butadiene for synthetic rubber [V]. No commercial customers or offtake volumes were disclosed.

Independent characterization. Cobalt was a venture-funded process-technology company whose value lay in its strains and patents, not in operating assets or revenue.

Strategy

There have been no initiatives in the last 24 months; the company has been defunct since 2015. Historically, its strategy had three phases.

  1. From 2005 to about 2012, it pursued low-capital continuous biofilm fermentation of cellulosic sugars to n-butanol [V].

  2. From 2010, it extended butanol into higher-value derivatives: jet fuel with the US Navy and butadiene with Asian partners [V].

  3. After about 2012, it pivoted toward retrofitting distressed ethanol plants, which made it resemble its competitors and weakened its differentiation [V].

Medium-term financial targets and guidance were never published.

Products & Services

The company had no commercial product catalog. Its technology assets, as listed in the 2015 liquidation summary, were as follows.

The cost figures are the company's own claims from a sale document and were never demonstrated at commercial scale. Pricing models, launch years and named flagship offerings are not publicly disclosed.

Product Portfolio

AssetDescriptionDisclosed metricSource

n-Butanol fermentation process

Clostridium-based fermentation of C5 and C6 sugars; originally continuous fixed-bed biofilm reactors

Claimed production cost below USD 700 per tonne

[V]

Biomass-to-sugar technology

Proprietary pretreatment and hydrolysis

Claimed sugar cost below USD 220 per tonne

[V]

Strain library

Product-tolerant, non-GMO organisms

240 strains, 8 species

[V]

Strain improvement methods

Patented

Number of patents not disclosed

[V]

Butanol-to-jet pathway

Licensed from the US Navy

Terms not disclosed

[V]

Butanol-to-butadiene pathway

Development work with Asian partners

—

[V]

“—” = not publicly disclosed.

Financial Narrative

No audited financial statements were ever published. Revenue, gross profit, operating income, EBITDA, net income, EPS, dividends, balance sheet items, cash flow items and all ratios are not publicly disclosed for any year. No chartable table is provided, because any number entered would be fabricated.

The only verified financial facts are funding events.

Commentary. The company consumed more than USD 90 million over roughly ten years without reaching commercial revenue. The pattern is typical of first-generation advanced biofuel ventures of the 2005–2015 period.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Funding Fact Details

Funding factAmount (USD Mn)

Series C, 2008

25

Series D, 2011

20

Cumulative capital invested by 2015, through at least Series E

More than 90

Analyst Conclusions

There is no guidance, no consensus and no forward catalyst. Bull and bear cases do not apply to a defunct company.

Monitorables. The only open questions are where the strain library and patents went after the auction, and whether any successor is using them.

Analyst verdict. No public company named Cobalt Technologies Inc. could be found. The matching entity is a private Californian biobutanol developer that failed in 2015, and it is not an investable or commercially active counterparty. Its history is still instructive. The company had real technical assets: a large non-GMO strain library, patented strain improvement methods and credible partners in Fluor, the US Navy and Rhodia/Solvay. It raised more than USD 90 million. It failed for three reasons. Scale-up of cellulosic fermentation took longer and cost more than venture investors would fund. The company abandoned the biofilm process that set it apart in favour of ethanol-plant retrofits that competitors could also offer. And the oil price fall from 2014 removed the price advantage that bio-based butanol needed, just as the collapse of other advanced biofuel ventures closed the funding window.

If the target is a different company (for example Cobalt Holdings plc, Cobalt Blue Holdings, Cobalt Blockchain or the private cybersecurity firm Cobalt), a reference URL, ticker or country of listing will allow a full 22-section profile. If the defunct biobutanol company is indeed the target, the items tagged [R] should be checked against the original 2008–2013 press releases, and the "public company" label should be corrected to "private, defunct".

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure

Rick Wilson

Chief Executive Officer

2008 to c. 2012

Bob Mayer

Chief Executive Officer

c. 2012 to 2015

Andy Meyer

President

—

Carole Cobb

Chief Operating Officer

—

David Walther

Vice President, R&D

—

“—” = not publicly disclosed.

Competitive Landscape

Key Competitors

CompetitorApproachNote

Green Biologics

n-Butanol by Clostridium fermentation

Seen in 2015 as making the steadiest progress

Gevo

Isobutanol

Listed on NASDAQ

Butamax (BP / DuPont joint venture)

Isobutanol

—

TetraVitae Bioscience

n-Butanol

Assets acquired by Eastman

Cathay Industrial Biotech

n-Butanol

Public offering withdrawn

METabolic EXplorer

Bio-based chemicals

—

Celtic Renewables

Butanol from whisky residues

—

Abengoa

Guerbet route from ethanol

—

Petrochemical n-butanol producers

Propylene-based oxo process

The price-setting incumbents

Recent Developments

The company has not operated since 2015. The last material events were the closure and auction reported in June 2015 and the creditor claims deadline of 15 October 2015 [V].

Company Snapshot

2005

Founded

CA, US

Headquarters

SWOT Analysis

Strengths

  • A library of 240 strains across 8 species [V].
  • Patented strain improvement methods [V].
  • Claimed butanol cost below USD 700 per tonne and sugar cost below USD 220 per tonne [V].
  • Proven ability to ferment C5 and C6 sugars from several cellulosic feedstocks [V].

Weaknesses

  • No commercial-scale plant after ten years [V].
  • More than USD 90 million consumed with no exit [V].
  • Strategic drift: a name change and a pivot away from the core biofilm technology [V].
  • Communications stopped in the final years, which hurt fundraising [V].

Opportunities

  • Jet fuel through the US Navy licence [V].
  • Butadiene through Asian partners [V].
  • South American bagasse through Solvay and GranBio [V].

Threats

  • Low oil and propylene prices [V].
  • Collapse of investor confidence in the sector [V].
  • Competing technologies and cheap retrofits of distressed ethanol plants [V].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.